F19 25 (Dapsone 25 mg)
Pill with imprint F19 25 is White, Round and has been identified as Dapsone 25 mg. It is supplied by Fera Pharmaceuticals, LLC.
Dapsone is used in the treatment of dermatitis herpetiformis; bullous pemphigoid; leprosy; leprosy, lepromatous; leprosy, tuberculoid (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for F19 25
Dapsone
- Imprint:
- F19 25
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Leprostatics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Fera Pharmaceuticals, LLC
- National Drug Code (NDC):
- 48102-0019
More about dapsone
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 11 Reviews – Add your own review/rating
- Drug class: leprostatics
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
